Cantabio Pharmaceuticals Inc

(CTBO)

By |

Profile

Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.

Contact Information

Website: www.cantabio.com
Main Phone: +1 844 200-2826
Address: 1250 Oakmead Parkway
State: CA
City / Town: Sunnyvale
Country: USA
Postal Code: 94085

Issuer Information

Exchange: OTO
CEO: Gergely Toth
Employees: 7
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.

Contact Information

Website: www.cantabio.com
Main Phone: +1 844 200-2826
Address: 1250 Oakmead Parkway
State: CA
City / Town: Sunnyvale
Country: USA
Postal Code: 94085

Issuer Information

Exchange: OTO
CEO: Gergely Toth
Employees: 7
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.00925 $ 0.00015 (1.65%)
Last Price 0.00925 Change $ 0.00015 Change % 1.65 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.0088 High 0.00999 Low 0.0088 Prev Close 0.0091
Last Trade Volume 9,078 52 Wk Hi 0.13 52 Wk Low 0.006
Market Cap 758,047 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 81,950,977.00 EPS (TTM) -0.07 PE Ratio N/A Exchange OTCPK